Diversification of caldesmon-linked actin cytoskeleton in cell motility

Cell Adhesion and Migration

Volumn 5, Issue 2, 2011, Pages 150-159

  Mayanagi, Taira ^a   Sobue, Kenji ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Actin cytoskeleton; Caldesmon; Cell invasion; Cell migration; Cytokinesis; Smooth muscle contraction; Transcription

Indexed keywords

ACTIN; CALCIUM; CALDESMON; CALMODULIN; MESSENGER RNA; MOLECULAR MARKER;

ACTIN FILAMENT; ACTIN MYOSIN INTERACTION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CYTOSKELETON; HUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION REGULATION;

VERTEBRATA;

EID: 79952335646     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.5.2.14398     Document Type: Review

References (117)

1. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell migration: integrating signals from front to back. Science 2003; 302:1704-9. (Pubitemid 37505725)
2. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003; 3:921-30. (Pubitemid 37500177)
3. Wang W, Goswami S, Sahai E, Byskoff JB, Segall JE, Condeelis JS. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005; 15:138-45. (Pubitemid 40332536)
4. Pantaloni D, Le Clainche C, Carlier MF. Mechanism of actin-based motility. Science 2001; 292:1502-6. (Pubitemid 32493411)
5. Chhabra ES, Higgs HN. Themany faces of actin: matching assembly factors with cellular structures. Nat Cell Biol 2007; 9:1110-21. (Pubitemid 47500485)
6. Sobue K, Muramoto Y, Fujita M, Kakiuchi S. Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin. Proc Natl Acad Sci USA 1981; 78:5652-5. (Pubitemid 12245208)
7. Sobue K, Seller JR. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J Biol Chem 1991; 266:12115-8. (Pubitemid 21907062)
8. Sobue K, Morimoto K, Inui M, Kanda K, Kakiuchi S. Control of actin-myosin interaction of gizzard smooth muscle. by calmodulin- and caldesmon-linked flip-flop mechanism. Biomed Res 1982; 3:188-96. (Pubitemid 12058804)
9. 2+-ATPase activity by caldesmon. J Biol Chem 1984; 259:13656-9.
10. Sobue K, Takahashi K, Wakabayashi I. Caldesmon150 regulates the tropomyosin-enhanced actin-myosin interaction in gizzard smooth muscle. Biochem Biophys Res Commun 1985; 132:645-51. (Pubitemid 16198673)
11. 2+-regulatory component of native smooth-musclethin filaments. Biochem J 1985; 231:517-22.
12. Bretscher A, Lynch W. Identification and localization of immuno reactive forms of caldesmon in smooth and nonmuscle cells: a comparison with the distributions of tropomyosin and alpha-actinin. J Cell Biol 1985; 100:1656-63. (Pubitemid 15099288)
13. Fürst DO, Cross RA, DeMey J, Small JV. Caldesmon is an elongated, flexible molecule localized in the actomyosin domains of smooth muscle. EMBO J 1986; 5:251-7.
14. Yamazaki K, Itoh K, Sobue K, Mori T, Shibata N. Purification of caldesmon and myosin light chain (MLC) kinase from arterial smooth muscle: comparisons with gizzard caldesmonand MLC kinase. J Biochem 1987; 101:1-9. (Pubitemid 17218588)
15. Dingus J, Hwo S, Bryan J. Identification by monoclonal antibodies and characterization of human platelet caldesmon. J Cell Biol 1986; 102:1748-57. (Pubitemid 16078759)
16. Ishikawa R, Yamashiro S, Matsumura F. Differential modulation of actin-severing activity of gelsolin by multiple isoforms of cultured rat cell tropomyosin. Potentiation of protective ability of tropomyosins by 83 kDa nonmuscle caldesmon. J Biol Chem 1989; 264:7490-7. (Pubitemid 19119165)
17. Warren KS, Shutt DC, McDermott JP, Lin JL, Soll DR, Lin JJ. Overexpression of microfilament-stabilizing human caldesmon fragment, CaD39, affects cell attachment, spreading and cytokinesis. J Cell Biol 1994; 125:359-68.
18. Ishikawa R, Yamashiro S, Kohama K, Matsumura F. Regulation of actin binding and actin bundling activities of fascin by caldesmon coupled with tropomyosin. J Biol Chem 1998; 273:26991-7. (Pubitemid 28471722)
19. Nomura M, Yoshikawa K, Tanaka T, Sobue K, Maruyama K. The role of tropomyosin in the interactions of F-actin with caldesmon and actin-binding protein (or filamin). Eur J Biochem 1987; 163:467-71. (Pubitemid 17036343)
20. Yamakita Y, Oosawa F, Yamashiro S, Matsumura F. Caldesmon inhibits Arp2/3-mediated actin nucleation. J Biol Chem 2003; 278:17937-44. (Pubitemid 36799400)
21. Yonezawa N, Nishida E, Maekawa S, Sakai H. Studies on the interaction between actin and cofilin purified by a new method. Biochem J 1988; 251:121-7.
22. Owada MK, Hakura A, IidaK, Yahara I, Sobue K, Kakiuchi S. Occurrence of caldesmon (a calmodulin-binding protein) in cultured cells: comparison of normal and transformed cells. Proc Natl Acad Sci USA 1984; 81:3133-7. (Pubitemid 14110692)
23. Sobue K, Tanaka T, Kanda K, Ashino N, Kakiuchi S. Purification and characterization of caldesmon77: a calmodulin-binding protein that interacts with actin filaments from bovine adrenal medulla. Proc Natl Acad Sci USA 1985; 82:5025-9. (Pubitemid 15249936)
24. Hayashi K, Yano H, Hashida T, Takeuchi R, Takeda O, Asada K, et al. Genomic structure of the human caldesmon gene. Proc Natl Acad Sci USA 1992; 89:12122-6. (Pubitemid 23004797)
25. Yano H, Hayashi K, Haruna H, Sobue K. Identification of two distinct promoters in the chicken caldesmon gene. Biochem Biophys Res Commun 1994; 201:618-26. (Pubitemid 24206917)
26. Hayashi K, Fujio Y, Kato I, Sobue K. Structural and functional relationships between h- and l-caldesmons. J Biol Chem 1991; 266:255-61.
27. Szpacenko A, Debrowska R. Functional domain of caldesmon. FEBS Lett 1986; 202:182-6. (Pubitemid 16003720)
28. Bartege A, Fattoum A, Derancourt J, Kassab R. Characterization of the carboxyl-terminal 10 kD acyanogens bromide fragment of caldesmon as an actin-calmodulin-binding region. J Biol Chem 1990; 265:15231-8.
29. Cross RA, Cross KE, Small JV. Salt dependent dimerisation of caldesmon. FEBS Lett 1987; 219:306-10.
30. Mabuchi K, Wang CL. Electron microscopic studies of chicken gizzard caldesmon and its complex with calmodulin. J Muscle Res Cell Motil 1991; 12:145-51.
31. Wang Z, Jiang H, Yang ZQ, Chacko S. Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmonmediated inhibition of actin filament velocity. Proc Natl Acad Sci USA 1997; 94:11899-904. (Pubitemid 27467814)
32. Li Y, Zhuang S, Guo H, Mabuchi K, Lu RC, Wang CA. The major myosin-binding site of caldesmon resides near its N-terminal extreme. J Biol Chem 2000; 275:10989-94. (Pubitemid 30212737)
33. Moody C, Lehman W, Craig R. Caldesmon and the structure of smooth muscle thin filaments: electron microscopy of isolated thin filaments. J Muscle Res Cell Motil 1990; 11:176-85.
34. Zheng PP, Weiden M, Kros JM. Hela l-CaD is implicated in the migration of endothelial cells/endothelial progenitor cells in human neoplasms. Cell Migr Adhes 2007; 1:84-91.
35. Hotulainen P, Lappalainen P. Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J Cell Biol 2006; 173:383-94.
36. Pellegrin S, Mellor H. Actin stress fibres. J Cell Sci 2007; 120:3491-9.
37. Tanaka J, Watanabe T, Nakamura N, Sobue K. Morphological and biochemical analyses of contractile proteins (actin, myosin, caldesmon and tropomyosin) in normal and transformed cells. J Cell Sci 1993; 104:595-606. (Pubitemid 23098697)
38. Guo H, Wang CLA. Specific disruption of smooth muscle caldesmon expression in mice. Biochem Biophys Res Commun 2005; 330:1132-7.
39. Zheng PP, Severijnen LA, van der Weiden M, Willemsen R, Kros JM. A crucial role of caldesmon in vascular development in vivo. Cardio Vasc Res 2009; 81:362-9.
40. Zheng PP, Severijnen LA, Willemsen R, Kros JM. Caldesmon is essential for cardiac morphogenesis and function: in vivo study using a zebrafish model. Biochem Biophys Res Commun 2009; 378:37-40.
41. Yano H, Hayashi K, Momiyama T, Saga H, Haruna M, Sobue K. Transcriptional regulation of the chicken caldesmon gene. Activation of gizzard-type caldesmon promoter requires a CArG box-like motif. J Biol Chem 1995; 270:23661-6.
42. Momiyama T, Hayashi K, Obata H, Chimori Y, Nishida T, Ito T, et al. Functional involvement of serum response factor in the transcriptional regulation of caldesmon gene. Biochem Biophys Res Commun 1998; 242:429-35. (Pubitemid 28412445)
43. Nishida W, Nakamura M, Mori S, Takahashi M, Ohkawa Y, Tadokoro S, et al. A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes. J Biol Chem 2002; 277:7308-17. (Pubitemid 34953125)
44. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001; 105:851-62. (Pubitemid 32635087)
45. Morita T, Mayanagi T, Sobue K. Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs). Exp Cell Res 2007; 313:3432-45. (Pubitemid 47407747)
46. Mayanagi T, Morita T, Hayashi K, Fukumoto K, Sobue K. Glucocorticoid receptor-mediated expression of caldesmon regulates cell migration via the reorganization of the actin cytoskeleton. J Biol Chem 2008; 283:31183-96.
47. Fukumoto K, Morita T, Mayanagi T, Tanokashira D, Yoshida T, Sakai A, et al. Detrimental effects of glucocorticoids on neuronal migration during brain development. Mol Psychiatry 2009; 14:1119-31.
48. Mukhopadhyay UK, Eves R, Jia L, Mooney P, Mak AS. p53 suppresses Src-induced podosome and rosette formation and cellular invasiveness through the upregulation of caldesmon. Mol Cell Biol 2009; 29:3088-98.
49. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, et al. A global map of p53 transcription-factor binding-sites in the human genome. Cell 2006; 124:207-19. (Pubitemid 43069320)
50. Ueki N, Sobue K, Kanda K, Hada T, Higashino K. Expression of high and low molecular weight caldesmonsduring phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 1987; 84:9049-53.
51. Hayashi K, Saga H, Chimori Y, Kimura K, Yamanaka Y, Sobue K. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem 1998; 273:28860-7. (Pubitemid 28507577)
52. Yoshida K, Nishida W, Hayashi K, Ohkawa Y, Ogara A, Aoki J, et al. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 2003; 108:1746-52. (Pubitemid 37243665)
53. MAPK-activated vascular smooth muscle cells. Circulation 2003; 108:2524-9.
54. Sobue K. Expression regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 1999; 190:105-18. (Pubitemid 29094995)
55. Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K. Changes in the balance of phosphoinositide- 3-kinase/protein kinase B (Akt) and the mitogenactivated protein kinases (ERK/p38 MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 1999; 145:727-40. (Pubitemid 29240851)
56. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-9. (Pubitemid 23132154)
57. Glukhova MA, Frid MG, Koteliansky VE. Phenotypic changes of human aortic smooth muscle cells during development and in the adult vessel. Am J Physiol 1991; 261:78-80.
58. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, et al. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 2001; 89:251-8. (Pubitemid 34132683)
59. Castellino F, Heuser J, Marchetti S, Bruno B, Luini A. Glucocorticoid stabilization of actin filaments: a possible mechanism for inhibition of corticotropin release. Proc Natl Acad Sci USA 1992; 89:3775-9.
60. Castellino F, Ono S, Matsumura F, Luini A. Essential role of caldesmon in the actin filament reorganization induced by glucocorticoids. J Cell Biol 1995; 131:1223-30.
61. 2+-calmodulin binding interferes with assembly of stress fibers and affects cell morphology, growth and motility. J Cell Sci 2004; 117:3593-604.
62. Mirzapoiazova T, Kolosova IA, Romer L, Garcia JG, Verin AD. The role of caldesmon in the regulation of endothelial cytoskeleton and migration. J Cell Physiol 2005; 203:520-8. (Pubitemid 40629014)
63. Eppinga RD, Li Y, Lin JL, Mak AS, Lin JJ. Requirement of reversible caldesmon phosphorylation at P21-activated kinase-responsive sites for lamellipodia extensions during cell migration. Cell Motil Cytoskeleton 2006; 63:543-62. (Pubitemid 44384280)
64. Lynch WP, Riseman VM, Bretscher A. Smooth muscle caldesmon is an extended flexible monomeric protein in solution that can readily undergo reversible intraand intermolecular sulfhydryl cross-linking. A mechanism for caldesmon's F-actin bundling activity. J Biol Chem 1987; 262:7429-37.
65. 2+-mechanisms in motile cells. J Biol Chem 1998; 273:23433-9.
66. 2+ sensitivity of smooth muscle contraction. J Biol Chem 2000; 275:1959-65.
67. Jiang Q, Huang R, Cai S, Wang CLA. Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability. J Biomed Sci 2010; 17:6.
68. Umekawa H, Hidaka H. Phosphorylation of caldesmon by protein kinase C. Biochem Biophys Res Commun 1985; 132:56-62. (Pubitemid 16196110)
69. Litchfield DW, Ball EH. Phosphorylation of caldesmon77 by protein kinase C in vitro and in intact human platelets. J Biol Chem 1987; 262:8056-60. (Pubitemid 17104261)
70. Tanaka T, Ohta H, Kanda K, Hidaka H, Sobue K. Phosphorylation of high-Mr caldesmon by protein kinase C modulates the regulatory function of this protein on the interaction between actin and myosin. Eur J Biochem 1990; 188:495-500. (Pubitemid 20109501)
71. Childs TJ, Watson MH, Sanghera JS, Campbell DL, Pelech SL, Mak AS. Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells. J Biol Chem 1992; 267:22853-9.
72. Adam LP, Hathaway DR. Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-caldesmon. FEBS Lett 1993; 322:56-60. (Pubitemid 23122384)
73. Patchell VB, Vorotnikov AV, Gao Y, Low DG, Evans JS, Fattoum A, et al. Phosphorylation of the minimal inhibitory region at the C-terminus of caldesmon alters its structural and actin binding properties. Biochim Biophys Acta 2002; 1596:121-30. (Pubitemid 34450845)
74. Goncharova EA, Vorotnikov AV, Gracheva EO, Wang CL, Panettieri RA Jr, Stepanova VV, et al. Activation of p38 MAP-kinase and caldesmon phosphorylation are essential for urokinase-induced human smooth muscle cell migration. Biol Chem 2002; 383:115-26. (Pubitemid 34224034)
75. Yamashiro S, Yamakita Y, Hosoya H, Matsumura F. Phosphorylation of non-muscle caldesmon by p34cdc2 kinase during mitosis. Nature 1991; 349169-72.
76. Mak AS, Watson MH, Litwin CM, Wang JH. Phosphorylation of caldesmon by cdc2 kinase. J Biol Chem 1991; 266:6678-81. (Pubitemid 21906272)
77. Sobieszek A, Sarg B, Lindner H, Seow CY. Phosphorylation of caldesmon by myosin light chain kinase increases its binding affinity for phosphorylated myosin filaments. J Biol Chem 2010; 391:1091-104.
78. Hettasch JM, Sellers JR. Caldesmon phosphorylation in intact human platelets by cAMP-dependent protein kinase and protein kinase C. J Biol Chem 1991; 266:11876-81. (Pubitemid 21907031)
79. Vorotnikov AV, Shirinsky VP, Gusev NB. Phosphorylation of smooth muscle caldesmon by three protein kinases: implication for domain mapping. FEBS Lett 1988; 236:321-4.
80. McManus MJ, Lingle WL, Salisbury JL, Maihle NJ. A transformation- associated complex involving tyrosine kinase signal adapter proteins and caldesmon links v-erbB signaling to actin stress fiber disassembly. Proc Natl Acad Sci USA 1997; 94:11351-6. (Pubitemid 27451002)
81. Wang Z, Danielsen AJ, Maihle NJ, McManus MJ. Tyrosine phosphorylation of caldesmon is required for binding to the Shc Grb2 complex. J Biol Chem 1999; 274:33807-13. (Pubitemid 129511700)
82. McManus MJ, Boerner JL, Danielsen AJ, Wang Z, Matsumura F, Maihle NJ. An oncogenic epidermal growthfactor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex. J Biol Chem 2000; 275:35328-34.
83. Hoffman LM, Jensen CC, Kloeker S, Wang CL, Yoshigi M, Beckerle MC. Genetic ablation of zyxin causes Mena/VASP mislocalization, increased motility and deficits in actin remodeling. J Cell Biol 2006; 172:771-82.
84. Sobue K, Fukumoto K. Caldesmon, an actin-linked regulatory protein, comes across glucocorticoids. Cell Adh Migr 2010; 4:185-9.
85. Hall A. Rho GTPases andthe actin cytoskeleton. Science 1998; 279:509-14. (Pubitemid 28067271)
86. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004; 265:23-32. (Pubitemid 38018819)
87. Wallar BJ, Alberts AS. The formins: active scaffolds that remodel the cytoskeleton. Trends Cell Biol 2003; 13:435-46. (Pubitemid 36897648)
88. Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003; 113:329-42. (Pubitemid 36556115)
89. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development and disease. J Cell Biol 2006; 172:973-81.
90. Thiery JP, Seleeman JP. Complex networks orchestrate epithelial mesenchymal transitions. Nat Rev Mol Cell Biol 1006; 7:131-42.
91. Tsuji T, Ibaragi S, Hu GF. Epithelial-Mesenchymal transition and cell cooperativity in metastasis. Cancer Res 2009; 69:7135-9.
92. Zavadil J, Bottinger EP. TGFbeta and epithelial-to-mesenchymal transitions. Oncogene 24:5764-74.
93. Morita T, Mayanagi T, Sobue K. Dual roles of MRTFs in epithelial-mesenchymal transition via slug induction and actin remodeling. J Cell Biol 2007; 179:1027-47.
94. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132:3151-61. (Pubitemid 41167144)
95. Fan L, Sebe A, Peterfi Z, Masszi A, Thirone ACP, Rotstein OD, et al. Cell contact-dependent regulation of epithelial-myofibroblast transition via the Rho-Rho kinase-phospho-myosin pathway. Mol Biol Cell 2007; 18:1083-97. (Pubitemid 46399511)
96. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 2010; 107:294-304.
97. Kuwahara K, Kinoshita H, Kuwabara Y, Nakagawa Y, Usami S, Minami T, et al. Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol Cell Biol 2010; 30:4134-48.
98. Tarone G, Cirillo D, Giancotti FG, Comoglio PM. Marchisio PC. Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp Cell Res 1985; 159:141-57. (Pubitemid 16247561)
99. Destaing O, Saltel F, Geminard JC, Jurdic P, Bard F. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actingreen fluorescent protein. Mol Biol Cell 2003; 14:407-16. (Pubitemid 36237005)
100. Linder S, Aepfelbacher M. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 2003; 13:376-85. (Pubitemid 36776715)
101. Sobue K. Involvement of the membrane cytoskeletal proteins and the src gene product in growth cone adhesion and movement. Neurosci Res Suppl 1990; 13:80-91.
102. Eves R, Webb BA, Zhou S, Mak AS. Caldesmon is an integral compotent of podosomes formation in smooth muscle cells. J Cell Sci 2006; 119:1691-702. (Pubitemid 43810996)
103. Morita T, Mayanagi T, Yoshio T, Sobue K. Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation. J Biol Chem 2007; 282:8454-63. (Pubitemid 47093626)
104. Yoshio T, Morita T, Kimura Y, Tsudii M, Hayashi N, Sobue K. Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation. FEBS Lett 2007; 581:3777-82. (Pubitemid 47102304)
105. Yoshio T, Morita T, Tsujii M, Hayashi N, Sobue K. MRTF-A/B suppress the oncogenic properties of v-rasand v-src-mediated transformants. Carcinogenesis 2010; 31:1185-93.
106. Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol 2009; 11:257-68.
107. Mukhopadhyay UK, Mooney P, Jia L, Eves R, Raptis L, Mak AS. Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion. Mol Cell Biol 2010; 30:4980-95.
108. Yamakita Y, Yamashiro S, Matsumura F. Characterization of mitotically phosphorylated caldesmon. J Biol Chem 1992; 267:12022-9.
109. Hosoya N, Hosoya H, Yamashiro S, Mohri H, Matsumura F. Localization of caldesmon and its dephosphorylation during cell division. J Cell Biol 1993; 121:1075-82. (Pubitemid 23154268)
110. Yamashiro S, Chern H, Yamakita Y, Matsumura F. Mutant caldesmon lacking cdc2 phosphorylation sites delays M-phase entry and inhibits cytokinesis. Mol Biol Cell 2001; 12:239-50. (Pubitemid 32060590)
111. Manes T, Zheng DQ, Tognin S, Woodard AS, Marchisio PC, Languino LR. αvβ3 integrin expression upregulates cdc2, which modulates cell migration. J Cell Biol 2003; 161:817-26. (Pubitemid 36648764)
112. Burgoyne RD, Cheek TR, Norman KM. Identification of a secretory granule-binding protein as caldesmon. Nature 1986; 319:68-70. (Pubitemid 16189833)
113. Janovick JA, Natarajan K, Longo F, Conn PM. Caldesmon: a bifunctional (calmodulin and actin) binding protein which regulates stimulated gonadotropin release. Endocrinology 1991; 129:68-74.
114. Hegmann TE, Schulte DL, Lin JL, Lin JJ. Inhibition of intracellular granule movement by microinjection of monoclonal antibodies against caldesmon. Cell Motil Cytoskeleton 1991; 20:109-20.
115. Helfman DM, Levy ET, Berthier C, Shtutman M, Riveline D, Grosheve I, et al. Caldesmon inhibits nonmuscle cell contaractility and interferes with formation of focal adhesions. Mol Biol Cell 1999; 10:3097-117.
116. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-9. (Pubitemid 47236692)
117. Thompson JD, Higgins DG, Gibson TJ. Clustal W - improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-80. (Pubitemid 24354800)